You have 9 free searches left this month | for more free features.

Abiraterone

Showing 1 - 25 of 447

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • Chicago, Illinois
    Northwestern University
Sep 27, 2023

Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • (no location specified)
Nov 10, 2023

Medicines Called Enzalutamide and Abiraterone in People With

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    Pfizer Inc
Jul 21, 2023

Prostate Cancer Trial (Dutasteride, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Jan 30, 2023

Prostate Cancer Trial in Tampa (Abiraterone Acetate)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 3, 2023

High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) Trial (dalpiciclib isethionate tablets; abiraterone acetate

Not yet recruiting
  • High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
  • dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets
  • placebo; abiraterone acetate tablets; prednisone tablets
  • (no location specified)
Oct 20, 2023

Prostatic Tumors Trial in Bronx (Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Bronx, New York
    Montefiore Medical Center
Sep 22, 2022

Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

Recruiting
  • Prostate Cancer
  • Prostate Cancer Metastatic
  • La Jolla, California
  • +1 more
Feb 2, 2023

Prostate Cancer Trial in Boston (ARN-509, Abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    (unnamed)
Jan 17, 2023

Prostate Cancer Trial (Neoadjuvant treatment)

Not yet recruiting
  • Prostate Cancer
  • Neoadjuvant treatment
  • (no location specified)
Oct 19, 2022

High-risk Prostate Cancer, Neoadjuvant Therapy Trial in Shanghai (Abiraterone acetate, Fluzoparib, Prednisone)

Recruiting
  • High-risk Prostate Cancer
  • Neoadjuvant Therapy
  • Abiraterone acetate
  • +4 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 6, 2022

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

Active, not recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Los Angeles, California
  • +6 more
Jan 18, 2023

Metastatic Castration-resistant Prostate Cancer Trial (Niraparib plus Abiraterone Acetate (Nira/AA) combination,

Available
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Aug 24, 2022

Abiraterone Acetate in Indian Metastatic, Castration Resistant

Withdrawn
  • Prostate Cancer
  • Abiraterone Acetate
  • Bangalore, India
  • +2 more
Aug 15, 2022

Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)

Not yet recruiting
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Enzalutamide 40 MG
  • Docetaxel injection
  • (no location specified)
Jan 27, 2023

Prostate Cancer Trial in United States (Abiraterone Acetate, Prednisone 5Mg Tab, DST-2970 (Abiraterone))

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Miami, Florida
  • +4 more
Dec 14, 2022

Prostate Cancer Metastatic Trial (MK-5684, Abiraterone acetate, Enzalutamide)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Nov 21, 2023

Prostate Cancer Castration-resistant Prostate Cancer Trial in Changsha (Abiraterone+SHR3162)

Active, not recruiting
  • Prostate Cancer Castration-resistant Prostate Cancer
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jul 6, 2022

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Prostatic Neoplasms
  • (no location specified)
Nov 21, 2023

Prostate Cancer Trial in Nanjing (Abiraterone Acetate, Prednisone, Goserelin 10.8 mg)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Dec 14, 2022

Neoadjuvant Therapy Trial in Nanjing (pamiparib, abiraterone, prednisone)

Recruiting
  • Neoadjuvant Therapy
  • Nanjing, Jiangsu, China
  • +2 more
Jan 3, 2023

Prostatic Tumors Trial in Worldwide (EPI-7386, Abiraterone Acetate, Prednisone or Prednisolone)

Suspended
  • Prostatic Neoplasms
  • Towson, Maryland
  • +3 more
Nov 3, 2022

Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (Abiraterone Oral Tablet, Prednisone tablet, Drug Dairy/Log)

Not yet recruiting
  • Prostate Cancer
  • +3 more
  • Abiraterone Oral Tablet
  • +3 more
  • (no location specified)
Apr 1, 2022

Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer Metastatic
  • Prostate Cancer
  • Houston, Texas
  • +2 more
Oct 7, 2022

Prostate Cancer Trial in Atlanta, Charleston (Opaganib, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Atlanta, Georgia
  • +1 more
Dec 28, 2022